Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / App Notes / 2021 / Fast and automated TSA-based multiplexed immunofluorescence on LabSat® Research

Fast and automated TSA-based multiplexed immunofluorescence on LabSat® Research

02/15/2021

Share

 

Unlike some of the existing multiplex approaches such as nextgeneration sequencing, mPCR, mass spectrometry, etc. multiplex immunofluorescence -also referred to as fluorescent multiplex immunohistochemistry- provides an edge to understand the coexpression and spatial distribution of multiple targets without compromising the tissue integrity.

 

 

Tyramide Signal Amplification (TSA) is an immunostaining method designed for its high sensitivity, capable of detecting low expressed epitopes and generate precise and clear results. Tyramide is coupled to a fluorophore to generate a signal amplification. Via a reaction mediated by HRP (horseradish peroxidase) coupled with the secondary antibody (AbII), tyramide turns into its active conformation and covalently binds to tyrosine residues proximal to the target epitope1.

To detect the next antigen, an elution step is required in order to detach the primary and secondary antibody (AbI and AbII) complex from the epitope. The already coupled tyramide remains attached to the epitope proximal region due to the covalent bonding.

 

 

>> Download the Application Note as a PDF

 

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Fast and automated TSA-based multiplexed immunofluorescence on LabSat® Research

February 15, 2021

A single NGS workflow for comprehensive genomic profiling

February 23, 2021

Biomarker Optimization on LabSat® Research

March 23, 2021

Fully automated quantification of Meropenem, Tazobactam, Piperacillin and Dexamethasone in plasma

May 4, 2021

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.